Faron Pharmaceuticals Oy

(LSE) FARN

Current Price£0.40

Market Cap£81.80M

Since IPO (2015)-82%

5 Year-87%

1 Year-80%

1 Month-13%

Faron Pharmaceuticals Oy Financials at a Glance

Market Cap

£81.80M

Revenue (TTM)

€0.00

Net Income (TTM)

-€7.87M

EPS (TTM)

-£0.21

P/E Ratio

-1.98

Dividend

£0.00

Beta (Volatility)

0.06 (Low)

Dividend

£0.00

Beta (Volatility)

0.06 (Low)

Price

£0.40

Volume

8,406

Open

£0.40

Price

£0.40

Volume

8,406

Open

£0.40

Previous Close

£0.41

Daily Range

£0.40 - £0.40

52-Week Range

£0.38 - £2.34

Estimated Earnings Date

Aug 26, 2026

Dividend

£0.00

Beta (Volatility)

0.06 (Low)

Price

£0.40

Volume

8,406

Open

£0.40

Previous Close

£0.41

Daily Range

£0.40 - £0.40

52-Week Range

£0.38 - £2.34

Estimated Earnings Date

Aug 26, 2026

FARN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Faron Pharmaceuticals Oy

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Juho Markku Jalkanen, PhD, MD

Website

www.faron.com

Headquarters

Turku, 20520, FI

FARN Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

45.13%

Return on Capital

-328.32%

Return on Assets

-45.68%

Earnings Yield

-50.51%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£81.80M

Shares Outstanding

199.51M

Volume

8.41K

Avg. Volume

120.46K

Financials (TTM)

Gross Profit

-€174.94K

Operating Income

-€8.38M

EBITDA

-€8.20M

Operating Cash Flow

-€34.41M

Capital Expenditure

€0.00

Free Cash Flow

-€34.41M

Cash & ST Invst.

€12.31M

Total Debt

€24.67M

Faron Pharmaceuticals Oy Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

€0.00

N/A

Gross Profit

-€174.94K

N/A

Gross Margin

0.00%

N/A

Market Cap

£81.80M

N/A

Market Cap/Employee

£3.27M

N/A

Employees

N/A

Net Income

-€7.83M

+54.5%

EBITDA

-€8.18M

+48.0%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

€12.31M

+79.1%

Total Debt

€24.67M

+88.2%

Accounts Receivable

€512.83K

N/A

Inventory

€0.00

N/A

Long Term Debt

€14.27M

+50.7%

Short Term Debt

€10.40M

+185.9%

Return on Assets

-45.68%

N/A

Return on Invested Capital

4.91%

N/A

Free Cash Flow

-€11.44M

-99658.3%

Operating Cash Flow

-€11.44M

-99658.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BVXP.LBioventix PLC

BVXP.LBioventix PLC£16.00-3.03%

HEMO.LHemogenyx Pharmaceuticals Plc

HEMO.LHemogenyx Pharmaceuticals Plc£7.60+0.80%

SAR.LSareum Holdings plc

SAR.LSareum Holdings plc£0.21+1.67%

IMM.LImmuPharma PLC

IMM.LImmuPharma PLC£0.04-1.34%

SCLP.LScancell Holdings plc

SCLP.LScancell Holdings plc£0.17-4.15%

BXP.LBeximco Pharmaceuticals Limited

BXP.LBeximco Pharmaceuticals Limited£0.43+0.00%

PRTC.LPureTech Health plc

PRTC.LPureTech Health plc£1.33-3.20%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$81.00+0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$36.31-0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.16+0.04%

NOKNokia

NOKNokia$13.28+0.02%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.29-0.03%

NKENike

NKENike$41.05-0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.21-0.05%

Questions About FARN

What is the current price of Faron Pharmaceuticals Oy?

Faron Pharmaceuticals Oy is trading at £0.40 per share.

What is the 52-week range for Faron Pharmaceuticals Oy?

Over the past 52 weeks, Faron Pharmaceuticals Oy has traded between £0.38 and £2.34.

How much debt does Faron Pharmaceuticals Oy have?

As of the most recent reporting period, Faron Pharmaceuticals Oy reported total debt of €21.55M.

How much cash does Faron Pharmaceuticals Oy have on hand?

Faron Pharmaceuticals Oy reported €10.75M in cash and cash equivalents in its most recent financial results.

What is Faron Pharmaceuticals Oy’s dividend yield?

Faron Pharmaceuticals Oy does not currently have a dividend yield.

Faron Pharmaceuticals Oy

Faron Pharmaceuticals Oy Financials at a Glance

FARN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Faron Pharmaceuticals Oy

FARN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Faron Pharmaceuticals Oy Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About FARN

What is the current price of Faron Pharmaceuticals Oy?

What is the 52-week range for Faron Pharmaceuticals Oy?

How much debt does Faron Pharmaceuticals Oy have?

How much cash does Faron Pharmaceuticals Oy have on hand?

What is Faron Pharmaceuticals Oy’s dividend yield?

Premium Investing Services